Development of a novel purification method for AAV vectors using tangential flow filtration
Biotechnology and Bioengineering · 2023-11 · 120 (11) · 3311-3321
DOI: 10.1002/bit.28524 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology and Bioengineering, online erschienen am 16.08.2023. Verfasst von Rimi Miyaoka und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Molecular and Medical Genetics, Center for Gene and Cell Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. Hauptthemen laut MEDLINE: Dependovirus, Genetic Vectors, Filtration. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Japan Agency for Medical Research and Development, The Japan Society for the Promotion of Science KAKENHI.
Abstract (Originalsprache)
Adeno‐associated virus (AAV) vector can efficiently transduce therapeutic genes in various tissue types with less side effects; however, owing to complex multistep processes during manufacture, there have been surges in the pricing of recently approved AAV vector‐based gene therapy products. This study aimed to develop a simple and efficient method for high‐quality purification of AAV vector via tangential flow filtration (TFF), which is commonly used for concentration and diafiltration of solutions during AAV vector purification. We established a novel purification method using TFF and surfactants. Treatment with two classes of surfactants (anionic and zwitterionic) successfully inhibited the aggregation of residual proteins separated from the AAV vector in the crude product by TFF, obtaining a clearance of 99.5% residual proteins. Infectivity of the AAV vector purified using the new method was confirmed both in vitro and in vivo, and no remarkable inflammation or tissue damage was observed in mouse skeletal muscle after local administration. Overall, our proposed method could be used to establish a platform for the purification of AAV vector.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Molecular and Medical Genetics, Center for Gene and Cell Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
- Medical Technology & Material Laboratory, Research and Business Development Division, Asahi Kasei Medical Co., Ltd., Shizuoka, Japan.
- Chromatography Media Business Division, HOYA Technosurgical Corporation, Tokyo, Japan.
ORCID-Profile: Rimi Miyaoka
Förderung
- The Japan Agency for Medical Research and Development
- The Japan Society for the Promotion of Science KAKENHI
Zitieren
APA
Miyaoka, R., Tsunekawa, Y., Kurosawa, Y., Sasaki, T., Onodera, A., Sakamoto, K., Kakiuchi, Y., Wada, M., Nitahara-Kasahara, Y., Hayashita-Kinoh, H., & Okada, T. (2023). Development of a novel purification method for AAV vectors using tangential flow filtration. Biotechnology and Bioengineering, 120(11), 3311-3321. https://doi.org/10.1002/bit.28524
Vancouver
Miyaoka R, Tsunekawa Y, Kurosawa Y, Sasaki T, Onodera A, Sakamoto K, et al. Development of a novel purification method for AAV vectors using tangential flow filtration. Biotechnology and Bioengineering. 2023;120(11):3311-3321. doi:10.1002/bit.28524
BibTeX
@article{Miyaoka2023,
author = {Miyaoka, Rimi and Tsunekawa, Yuji and Kurosawa, Yae and Sasaki, Takako and Onodera, Azusa and Sakamoto, Kenji and Kakiuchi, Yuko and Wada, Mikako and Nitahara-Kasahara, Yuko and Hayashita-Kinoh, Hiromi and Okada, Takashi},
title = {Development of a novel purification method for AAV vectors using tangential flow filtration},
journal = {Biotechnology and Bioengineering},
year = {2023},
volume = {120},
number = {11},
pages = {3311--3321},
doi = {10.1002/bit.28524}
}
EUVIMED